On July 10, 2019, #CDHT was proud to welcome Gilead Sciences, one of the world’s top 500 enterprises to settle into CDHT’s biomedical development area for Chengdu’s #pharmaceuticalindustry. Gilead Sciences is a well-established R&D-based #biopharmaceutical company dedicated to providing innovative and simplified treatments for patients with severe diseases worldwide.
Throughout the years, CDHT’s biomedical development area has been awarded the titles of national biological industry base, national medicine export base, national traditional Chinese medicine modernization science and technology industry base, and national biomedical materials and hi-tech equipment #industrialization base.
Later the same year, Gilead was also awarded the titles of national biological industry base, national medicine export base, national science and technology industry base of Chinese medicine modernization, and national high-tech industrialization base of biomedical materials and medical devices.
Together, the cooperation between Gilead Sciences and CDHT will open new pathways for the development of #biomedicalresearch and operation in the world.